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Background: Beliefs play a crucial role in medication adherence. Interestingly, the  relationship 
between beliefs and adherence varies when different adherence measures are used. How adher-
ence, in turn, is related to asthma symptoms is still unclear. Our aim was to investigate the 
relationship between beliefs (ie, necessities and concerns) about inhaled corticosteroids (ICS) 
and subjectively as well as objectively measure adherence and the agreement between these 
measures. Further, the relationship between adherence and asthma symptoms was examined.
Methods: A total of 280 patients aged 18–80 years who filled at least two ICS prescriptions 
in the preceding year were recruited to complete a questionnaire. The questionnaire included 
the Beliefs about Medicines Questionnaire to assess necessity beliefs and concerns about ICS, 
four questions about ICS use to measure self-reported adherence, and the Asthma Control 
Questionnaire to assess asthma symptoms. Proportion of days covered was used to determine 
pharmacy refill adherence.
Results: Data from 93 patients with asthma were analyzed. Necessities were positively related 
to self-reported adherence (P = 0.01). No other associations were found between beliefs and 
subjective or objective adherence. There was no correlation between self-reported and refill 
adherence. Participants were significantly (P , 0.001) less adherent according to self-report 
data (24.4%) than according to pharmacy data (57.8%). No relationship was found between 
adherence and asthma symptoms.
Conclusion: Higher necessities are associated with higher self-reported adherence, suggesting 
that it could be more important to focus on necessities than on concerns in an attempt to improve 
adherence. Self-reported and refill adherence measurements cannot be used interchangeably. 
No relationship between adherence and asthma symptoms was found.
Keywords: asthma, inhaled corticosteroids, adherence, medication beliefs, asthma 
symptoms
Introduction
Asthma affects approximately 520,000 people in The Netherlands1 and is an  increasing 
public health concern worldwide.2 The goal in treating asthma is achieving and 
 maintaining symptom control with a minimum number of drugs. Inhaled corticosteroids 
(ICS) are the most effective anti-inflammatory medications in treating asthma, and are 
used as first-line therapy in its long-term or even lifelong treatment.3–6 Unfortunately, 
ICS adherence, ie, the degree to which patients take their ICS as prescribed by their 
care provider7,8 seems to be very poor (approximately 50%).9,10
There are several factors related to medication adherence,11–14 of which patients’ 
beliefs about medication are considered an important aspect in their motivation to 
take the medication as prescribed.15 Specific beliefs are related to thoughts about the 
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patient’s own medication and appear to be more strongly 
associated with medication adherence than general beliefs 
about medication.16 Two specific medication beliefs can be 
distinguished according to the often used framework devel-
oped by Horne et al,17 ie, necessities and concerns. Patients 
can have specific thoughts related to the necessity of their 
medication in maintaining their health. On the other hand, 
patients can also have specific feelings (concerns) about the 
possible harmful long-term effects and dependence on their 
medication.
Numerous types of measurement exist to assess adher-
ence, ie, direct, indirect, subjective, and objective methods.18 
Menckeberg et al9 have already demonstrated that beliefs 
about ICS correlate with both self-reported adherence and 
refill adherence. In a group of patients aged 18–45 years, 
higher concerns were correlated with lower self-reported 
adherence and higher necessities with higher refill adherence. 
Because of the great variance in measurements which can be 
applied to assess adherence, further characterization of the 
association between (non)adherence and medication beliefs 
remains relevant.9,19 Furthermore, we do not know whether 
these relationships can be replicated and whether they also 
exist in patients older than 45 years.
To some extent, studies have indicated a (noncausal) 
relationship between adherence with ICS and asthma symp-
toms, often using a self-reported scale to assess patient 
adherence.20–23 Given the subjectivity of self-report instru-
ments, it is important to use objective methods as well to 
determine the relationship between adherence and asthma 
symptoms. Currently, this relationship has not been fully 
elucidated.24,25
The aim of this study was to determine the relationship 
between medication beliefs (ie, necessities and concerns) and 
adherence with ICS in an adult population aged 18–80 years. 
In addition, it aimed to examine the association between 
adherence and asthma symptoms. Finally, objective and 
subjective methods of measuring adherence were compared 
which give insight into their agreement.
Materials and methods
Research design and setting
This study is part of a larger research project investigat-
ing communication about ICS inhalers in pharmacies. 
The research proposal was assessed by the medical ethics 
 committee of the University Medical Centre Utrecht. The 
medical ethics committee concluded that it was unneces-
sary to assess the proposal according to the law on medical 
scientific research involving human beings.
This cross-sectional study was conducted between May 
and July 2011 in one pharmacy situated in The Netherlands. 
Participants were selected from the pharmacy system using 
ATC codes (unique codes for each medicine according to 
the Anatomical Therapeutic Chemical classification system) 
for ICS and combination products of β
2
-agonists and ICS.26 
Adult patients aged 18–80 years were invited to participate 
if they had used ICS for at least one year, and had filled at 
least two ICS prescriptions within the last year. Patients were 
excluded if they used a combination of medicines together 
with their ICS (eg, ICS and tiotropium), which indicates 
chronic obstructive pulmonary disease (COPD) instead of 
asthma.
Patients and procedure for data collection
A total of 280 patients met the selection criteria and were 
invited to participate. The sample size was determined by 
the number of patients in this particular pharmacy who met 
the inclusion criteria. A questionnaire had to be completed 
by the participants, and pharmacy data were extracted from 
the year prior to the inclusion date.
Participants were recruited by sending an information 
package with an information letter, an informed consent 
form, a questionnaire, and a return envelope. The front page 
of the questionnaire was marked with a sticker with the name 
of the ICS used by the patient. This made clear to patients 
that the questions were about their anti-inflammatory drugs 
(ICS) and not about other (inhaled) medicines.
Measurement instruments
The questionnaire included questions about sociodemo-
graphics (ie, age, gender, and education). In addition, 
questions were asked about smoking and sport habits and 
the indication for ICS prescription (for asthma [symptoms], 
COPD or not known). Furthermore, two questions about 
ICS inhaler use (ICS use/day and puffs of ICS/time) were 
included.
ICS adherence was measured as self-reported adherence 
and as refill adherence. Self-reported adherence was mea-
sured using a scale with four dichotomous items comparable 
but not identical to the items from the Morisky scale.27 This 
scale was used to determine medication adherence in a sub-
jective way and consists of four questions which can only 
be answered with yes (0 point) or no (1 point). An example 
of the questions is “Are you careless sometimes about tak-
ing your medicine?” Scores can be added up to generate a 
score range of 0–4. A score closer to four indicates higher 
adherence. Participants were divided into two groups, ie, 
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medication adherent (score of 4) and medication nonadher-
ent (score ,4).28 In addition, the scores were also used as 
continuous data. Pharmacy dispensing data for ICS were 
used to determine objectively measured refill adherence 
by calculating the proportion of days covered29 by dividing 
the total of one day’s supply by the total number of days 
evaluated, multiplied by 100%. The evaluation period for 
every person was about 365 days (one year). Episodes of 
medication use were truncated if the medication gap was 
$182 days (half a year). After calculation of refill adher-
ence via pharmacy data, participants were divided into 
adherent users and nonadherent users. Patients were clas-
sified as nonadherent at the commonly used cutoff point 
of #80%.30–32
The validated Beliefs About Medicines Questionnaire 
(BMQ-specific) was used to assess specific ICS beliefs.16 
The BMQ consists of a necessity scale and a concerns scale, 
each containing five 5-point Likert scaled items, ranging 
from “strongly disagree” to “strongly agree”. An example 
of a concerns item is “Having to take medicines worries 
me” and of a necessity item “My health in the future will 
depend on my medicines”. The scores were added up for 
both scales to produce a score ranging from 5 to 25. Higher 
scores indicate stronger beliefs. To determine which of 
the two scales was most important for the participants, a 
necessity-concerns differential was calculated by subtract-
ing concerns scores from necessity ones, leading to a score 
range of -20 to 20. Lower scores indicate lower perceived 
necessity, which suggests more negative feelings towards 
using ICS medication.9,33 To assess the association between 
medication beliefs and adherence from a more categorical 
perspective, four categories were created: patients with low 
necessities and high concerns, patients with low necessities 
and low concerns, patients with high necessities and high 
concerns, and patients with high necessities and low con-
cerns. These groups can be classified as skeptical, indiffer-
ent, ambivalent, and accepting, respectively.9,34 To determine 
low/high necessity/concerns, the scale midpoint (indicated 
as 15) was used as the cutoff.
The validated, six-item Asthma Control Questionnaire 
(ACQ) without Lung Function was used to assess asthma 
control,35,36 rated on a 7-point Likert scale from “no impair-
ment” (0 points) to “maximum impairment” (6 points). 
An example of a question is “On average, during the past 
week, how often were you woken by your asthma during 
the night?” All items are added up and divided by six; a 
score of 1.5 or higher was regarded as not well controlled 
asthma.36,37
Data analysis
Pharmacy and questionnaire data were manually transferred 
into a Statistical Package for the Social Sciences version 17.0 
database (SPSS Inc, Chicago, IL, USA). A one-sample test 
of proportions was used to determine whether patients were 
more or less adherent according to self-reported or refill 
adherence. A Pearson’s Chi-square test was used to deter-
mine associations between refill adherence and self-reported 
adherence, and between refill/self-reported adherence and 
BMQ attitudinal group. Multiple regression analyses were 
performed, all adjusting for age, gender, educational level, 
and exercise habits. Linear and logistic regression analyses 
of necessities and concerns on self-reported adherence 
were done. Logistic regression analyses were carried out to 
assess the relationship between medication beliefs and refill 
adherence, and the association between asthma control and 
self-reported and refill adherence, respectively.
Results
Participants
Questionnaires were returned by 142 of 280 patients 
(response rate 50.7%). Seven questionnaires were returned 
as “wrongly addressed” (net sent rate, 96.8%). Of the 142 
respondents, 93 reported having asthma, 21 reported having 
COPD, and 12 suffered from both asthma and COPD. Sixteen 
respondents reported their health problem as unknown or 
did not complete the question (missing). For the purpose of 
this study, only the questionnaires of patients with asthma 
without COPD (n = 93) were analyzed. Three-quarters of 
the participants were highly educated. Approximately, half 
of the participants was aged 18–44 years and the other half 
was 45 years or older (Table 1).
Refill and self-reported adherence
The mean refill adherence rate was 79.1% ± 17.2%, ranging 
from 38.4% to 100.0% (n = 90). Table 2 illustrates the distri-
bution of participants over the self-reported adherence scores 
(ie, times answered “no” to a question). A higher score indi-
cates a higher adherence rate. Almost a quarter of the patients 
(24.4%) answered “no” to all questions. However, none of 
the participants stopped using their medicine when they felt 
worse when taking it, so no participant did not answer “no” 
at all. Most participants (65.6%) forgot their medicine at least 
once in the preceding month (data not shown).
A one-sample test of proportions showed that participants 
were significantly less adherent according to self-report 
(24.4% adherent) than according to pharmacy data (57.7% 
adherent) (P , 0.001). Moreover, no association existed 
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Table 1 Participant characteristics
Participants,  
n = 93 (100%)
Gender
 Male 38 (40.9)
 Female 55 (59.1)
Age, years
 Mean (years) ± SD (range) 43.7 ± 14.5 (18–77)
Age group, years
 18–44 47 (50.5)
  $45 46 (49.5)
Education
 Low 10 (10.8)
 Intermediate 13 (14.0)
 High 70 (75.3)
Living situation
 Living with parents/family 4 (4.3)
 Married/cohabiting 53 (57.0)
 Single with children 3 (3.2)
 Single without children 23 (24.7)
  Student house/residential community 10 (10.8)
Smoking habits
 Nonsmoker 63 (67.7)
 Ex-smoker 22 (23.7)
 Smoker 8 (8.6)
Exercise habitsa
 Low 14 (15.1)
 Intermediate 29 (31.2)
 High 50 (53.8)
Type of ICS
 Budesonide 22 (23.7)
 Ciclesonide 10 (10.8)
 Fluticasone 48 (51.6)
 Beclomethasone 13 (14.0)
Type of medication
 ICS alone 45 (48.4)
 ICS + long-acting β2-agonistb 48 (51.6)
Frequency of administration (daily)
 1–1.5 12 (14.1)
 2 73 (85.9)
Notes: aLow, 30 minutes of exercise less than 3 days a week; intermediate, 
30 minutes of exercise 3–4 days a week; high, 30 minutes of exercise $5 days a 
week. Country of origin is not taken into account, because only one respondent 
(1.08%) was non-western. bFixed-dose combination.
Abbreviation: ICS, inhaled corticosteroids.
Table 2 Distribution for patient self-reported adherence scores 
using the self-reported adherence scale
Adherence scorea n (%)
0 0 (0.0%)
1 18 (20.0%)
2 25 (27.8%)
3 25 (27.8%)
4 22 (24.4%)
Note: aScore ,4, nonadherent with medication; score of 4, adherent with 
medication.
Table 3 Participants classified as (non)adherent according to 
self-report or pharmacy data (n = 88, five missing)
Self-reported adherence P-value‡
Adherent Nonadherent
Refill adherence
 Nonadherent 8 (9.1%) 30 (34.1%) 0.46
 Adherent 14 (15.9%) 36 (40.9%)
Note: ‡P-value calculated by Pearson Chi-square test.
between self-reported adherence and refill adherence 
(Table 3). Only 50% (15.9% + 34.1%) of the participants 
were classified in the same adherence category according to 
subjective and objective adherence measurements. The mean 
refill adherence rate in self-reported adherent participants 
did not differ significantly from self-reported nonadherent 
participants.
Medication beliefs
The internal consistency of the necessity scale of the BMQ 
was good (Cronbach’s α = 0.81) and the consistency of 
the concerns scale was moderate (Cronbach’s α = 0.65). 
More than one third of the participants (39.9%) had doubts 
about the necessity of using ICS (scores below scale mid-
point). Approximately three-quarters (76.7%) indicated few 
concerns about using ICS (scores below scale midpoint). 
Participants scored higher on the necessity scale than on the 
concerns scale (necessity-concerns difference 3.77 ± 4.37, 
ranging from -8 to 15), which indicates a positive evaluation 
towards use of ICS medication.
Beliefs about ICS and adherence
Figure 1 shows the distribution of participants over the four 
BMQ categories with percentage of adherent participants 
within each group. Most participants reported high necessi-
ties and low concerns (accepting, n = 38; 43.7%), whereas 
the skeptical group (low necessities, high concerns) consisted 
of only five participants (5.7%). The percentage of adherent 
patients according to self-report was lowest in the indifferent 
group (13.3%) and skeptical group (0.0%) and highest in the 
accepting group (33.3%). According to refill adherence, the 
percentage of adherent patients was highest in the skeptical 
group (80.0%); however, the number of participants in this 
group is very low. Refill adherence is also high in the accept-
ing group (63.2%), followed by the indifferent group (55.2%) 
and ambivalent group (40.0%). No associations between 
BMQ category and, on the one hand, self-reported adherence, 
and, on the other hand, refill adherence were found.
Multiple linear regression analysis revealed a significant 
positive association (P = 0.01) between necessities and 
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self-reported adherence, adjusted for confounders (Table 4). 
 Multiple logistic regression analysis confirmed this asso-
ciation (P = 0.02, data not shown). Table 5 illustrates that 
necessities are higher (P = 0.01) in participants classified as 
self-reported adherent (17.1 ± 3.3) than in those classified as 
Necessity 
High 
Accepting (n = 38) 
a33.3% 
b63.2%
Ambivalent (n = 15) 
a26.7% 
b40.0% 
Low Belief High Concerns 
a13.3%  
b55.2%  
Indifferent (n = 29) 
a0.0% 
b80.0% 
Skeptical (n = 5)
Low 
Figure 1 Distribution of participants among the four Beliefs About Medicines Questionnaire categories and percentage of adherent participants according to self-reported 
and refill adherence per category. aPercentage of adherence participants according to self-reported adherence; bpercentage of adherence participants according to refill 
adherence.
Table 4 Association between necessities and self-reported 
adherence adjusting for age, gender, education level, and exercise 
habits by multiple regression analysis
B-coefficient (SE) 95% CI
Constant 0.98 (0.76) -0.54 to 2.49
Necessities 0.06 (0.02)** 0.01 to 0.11
Age 0.02 (0.008)* 0.0001to 0.03
Gender
 Femalea – –
 Male 0.25 (0.21) -0.18 to 0.67
Education level
 Lowa – –
 Intermediate -1.26 (0.47)** -2.15 to -0.38
 High -0.37 (0.38) -1.12 to 0.38
Exercise habits
 Lowa – –
 Intermediate 0.26 (0.34) -0.41 to 0.93
 High 0.28 (0.31) -0.33 to 0.89
Notes: aReference category. *P , 0.05; **P = 0.01.
Abbreviations: CI, confidence interval; SE, standard error.
self-reported nonadherent (14.5 ± 4.3). However, no asso-
ciation was found between necessities and refill adherence. 
The regressions of self-reported (linear) and refill adherence 
(logistic) regarding concerns did not show a significant 
relationship, so there was no association between concerns 
and adherence.
Adherence and asthma symptoms
Internal consistency of the ACQ was good (Cronbach’s 
α = 0.84). Most participants (84.6%) had well controlled 
asthma (ACQ ,1.5). No significant associations were 
found between self-reported or refill adherence and asthma 
control. Furthermore, logistic regression analyses of neces-
sities and concerns on asthma control did not reveal an 
association.
Discussion
Relationship between beliefs about  
ICS and adherence
According to the BMQ scores, participants’ beliefs regard-
ing concerns and necessities were favorable with regard 
to the use of ICS because scores on the necessity scale 
were high and those on the concerns scale relatively low. 
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According to these results, high adherence rates would be 
expected, because high needs and low concerns increase 
adherence.9,13,38 Nevertheless, this was not found in this 
study. Self-reported adherence was low, and although refill 
adherence was over two times higher than self-reported 
adherence, no association between beliefs and refill adher-
ence was found.
Menckeberg et al9 showed that higher necessities were 
correlated with higher refill adherence and also showed a 
correlation between concerns and self-reported adherence. 
The present study only found a positive association between 
self-reported adherence and necessities. This is consistent 
with findings in other studies, in which a stronger belief in 
the necessity of medication was also a predictor for higher 
adherence.39,40
Most participants reported low concerns and high necessi-
ties, and were classified as “accepting” according to the four 
attitudinal types. In this group, the self-reported adherence 
level was the highest, although no significant differences in 
adherence rates were found between the four groups. No 
significant association between the attitudinal groups and 
adherence was seen either.
Self-reported adherence levels were highest in the accept-
ing and ambivalent group, which is similar to the findings of 
Menckeberg et al.9 In contrast, the present study shows the 
highest refill adherence rates in the accepting and skeptical 
group. However, adherence rates in the skeptical group are 
less reliable, since only five participants were classified in 
this group.
Relationship between adherence  
and asthma symptoms
Consistent with the findings of Menckeberg et al,9 adherence 
with ICS was not associated with asthma control. This is in 
contrast with a study by Clatworthy et al,20 which showed 
an association between not well controlled asthma and low 
self-reported adherence with ICS. A possible explanation for 
this is that only a small proportion of the participants did not 
have well controlled asthma (15.4%).
Even though a positive relationship between adherence 
and asthma symptoms would be expected, well controlled 
asthma could also lead to less ICS use. Since patients could 
experience a low need for ICS when not suffering from 
clinically relevant symptoms, this could lead to nonadher-
ence as well.41,42
Relationship between self-reported  
and refill adherence
This study showed no association between self-reported 
adherence and refill adherence (continuous as well as 
dichotomous self-reported adherence) to ICS. Only half of 
the participants were classified in the same group according 
to subjective and objective ICS adherence. Approximately 
two-thirds of the participants who were classified as adher-
ent based on pharmacy data were classified as nonadherent 
according to self-report. This could be due to the relatively 
strict classification of adherent/nonadherent participants via 
self-report. Answering “yes” to the question “Do you ever 
forget to take your medicine?” on the self-reported adher-
ence scale made a participant nonadherent. Classification 
as adherent/nonadherent according to pharmacy data is less 
strict; even if a participant misses up to 20% of their medica-
tion, the participant is still regarded as adherent. This allows 
participants to be classified as adherent even if they behave 
nonadherently in some way. Besides, even if a participant is 
adherent according to refill adherence, it is still questionable 
whether the medicine is actually taken. A prescription can 
be filled at the pharmacy, but it is unknown what happens 
thereafter. This problem is not present with self-reported 
adherence.
It is very important how the threshold in adherence/ 
nonadherence is established, because this is the basis on which 
conclusions are drawn. This is why a post hoc analysis was 
performed in which the threshold of the self-reported adher-
ence scale was changed from a score of 4 as adherent to a score 
of $3 as adherent, after which the classification in adherence 
changed. Another reason to perform this analysis is that 
mean refill adherence in self-reported adherent participants 
Table 5 Beliefs in refill/self-reported adherent and nonadherent participants
Beliefs Self-reported adherence Refill adherence
Nonadherent Adherent Nonadherent Adherent
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Concerns 10.7 ± 3.4 (n = 68) 11.5 ± 3.7 (n = 22) 11.7 ± 4.0 (n = 38) 11.2 ± 3.4 (n = 52)
Necessities 14.5 ± 4.3 (n = 68) 17.1 ± 3.3* (n = 22) 15.2 ± 3.9 (n = 38) 15.0 ± 4.5 (n = 52)
Note: *P-value calculated by independent t-test, P , 0.05.
Abbreviation: SD, standard deviation.
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did not differ from self-reported nonadherent participants. 
Self-reported adherence shifted from 22 adherent participants 
to 47 adherent participants (52.2%). Using this format, self-
reported adherent participants had a mean refill adherence of 
82.5% ± 15.9%, which is significantly higher (P = 0.03) than 
the mean refill adherence of 74.7% ± 17.9% of the nonadher-
ent participants according to self-report. This is an additional 
indication that the threshold of the self-reported adherence 
scale used divides people into nonadherent/ adherent in a 
stricter manner than does refill adherence.
To provide an easy method for filling in the questions 
on the self-reported adherence scale, the instruction of 
the questionnaire indicated that the statements that had to 
be completed were regarding the preceding month. The 
consequence of this is that it is more difficult to compare 
self-reported adherence with refill adherence, because the 
latter method covered adherence during the preceding year. 
However, if the statements referred to the preceding year, 
potentially even more participants would be classified as 
self-reported nonadherent.
Refill adherence has more inherent difficulties. First of 
all, objective adherence measured with pharmacy data can 
be calculated in different ways.43 Second, many assumptions 
have to be made in order to calculate refill adherence. This is 
especially the case for calculations which determine adher-
ence with ICS. For example, sometimes dosage instructions 
were not clear (eg, 1–2 puffs per day and usage known), 
and the researchers had to choose the most obvious instruc-
tion. In addition, assessment was done using treatment 
episodes. These introduce bias, because shorter periods 
(,30 days) result in higher adherence rates and longer 
periods (.180 days) result in lower adherence rates. In the 
present study, episodes were defined as #182 days (half a 
year). Self-reported adherence with ICS is not influenced 
by this problem because it does not depend on episodes. 
The 80% cutoff for determination of adherent participants 
is also an assumption. Shifting this cutoff provides a differ-
ent classification of adherent participants. Altogether, this 
leads to refill adherence with ICS being a rough estimation. 
Using both self-reported and refill rates to indicate a person’s 
nonadherence probably offers the most valid estimation in 
daily practice.
In this study, no association could be established between 
medication beliefs, adherence, and asthma symptoms. 
These relationships seem to operate in a complex manner, 
in which each element could influence another in a positive 
or contrary way. Adherence is expected to enhance asthma 
control, whereas asthma control could lead to  nonadherence. 
 Moreover, asthma symptoms can affect beliefs about 
 medication, which in turn affect adherence with ICS, and 
consequently asthma symptoms themselves can change. 
Further research is needed to study these hypotheses.
Limitations
The study population had some unique characteristics, 
which restricts the ability to extrapolate its results to other 
 populations. An important issue is the high educational 
level of the participants, in that 75.3% was highly educated, 
while in the general Dutch asthma population only 24.2% 
has been classified as highly educated.44 Higher education 
can lead to nonrepresentative adherence levels, because low 
levels of education have been associated with poorer adher-
ence to ICS.45
Distinguishing between asthma and COPD in the phar-
macy data was done on the basis of using comedication 
prescribed for COPD, which is not an ideal method. This was 
shown by a relatively large number of participants (14.8%) 
who described their health problem as COPD instead of 
asthma. An additional explanation for this large number could 
be that not all participants were aware of the exact nature of 
their health problem. It has been shown that not everybody 
with asthma actually knows that they have asthma.3
In addition, only data from one pharmacy were used in 
this study. This could also explain the higher educational 
level of the study participants, because the particular phar-
macy is situated in a wealthier neighborhood in Utrecht, 
The Netherlands.
Implications for clinical practice
This study showed that higher necessities were associated 
with higher self-reported adherence. Education about the 
need for ICS medication could potentially be beneficial in 
patients with lower perceived needs.8 In this study, 11.3% 
of respondents did not know the reason for their ICS 
 prescription. This implies that more information should 
be provided by prescribers as well as pharmacists. This 
could lead to an improvement in understanding the disease 
and medication, and better awareness about the need for 
 medication. Interventions by pharmacists which are intended 
to increase knowledge about medication and disease are 
indeed known to improve clinical outcomes and are therefore 
recommended.46–48
Conclusion
We found that higher necessities are related to higher self-
reported adherence. This suggests that in order to increase 
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adherence it is more important to focus on strengthening 
needs than on diminishing concerns. The present study 
did not find an association between adherence and asthma 
 symptoms. However, based on this study alone it cannot 
be ruled out that this association does not exist. Finally, 
there was no relationship between self-reported and refill 
adherence with ICS. This indicates that it cannot be simply 
assumed that self-reported adherence is a correct represen-
tation of refill adherence. Therefore, it is important to take 
both measurement methods into account in clinical practice 
as well as in further research.
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